Skip to main content
Clinical Trials/NCT04315168
NCT04315168CompletedNot Applicable

Evaluation of Safety and Efficacy of the FRED and FRED JR Devices for Intracranial Aneurysm Treatment

Microvention-Terumo, Inc.1 site in 1 country135 target enrollmentStarted: June 12, 2020Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Sponsor
Enrollment
135
Locations
1
Primary Endpoint
Mortality Rate

Study Overview

Brief Summary

A French, multicenter, prospective, observational, "real-world" assessment of the safety and efficacy of FRED and FRED Jr devices in the treatment of intracranial aneurysms

Detailed Description

Post Market Clinical Follow-up. Multicenter observational study. Treatment and follow-up far at least 12 months as per standard of care.

Sample Size: 138 patients.

Study Design

Study Type
Observational
Observational Model
Cohort
Time Perspective
Prospective

Eligibility Criteria

Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Patient with an intracranial aneurysm for which an endovascular treatment is indicated with the device FRED or FRED JR
  • Patient or patient's legally authorized representative has been informed about the study and does not oppose the collection of his/her personal data

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Mortality Rate

Time Frame: 1 year

Percentage of patients with neurological death

Morbidity Rate

Time Frame: 1 year

Percentage of patients with major ipsilateral stroke

Secondary Outcomes

  • modified Rankin Score(1 year)
  • Complete aneurysm occlusion rate(1 year)
  • Retreatment Rate(1 year)
  • Patient description(1 year)

Investigators

Sponsor
Microvention-Terumo, Inc.
Sponsor Class
Industry
Responsible Party
Sponsor

Study Sites (1)

Loading locations...

Similar Trials

FRED and FRED JR Devices for Intracranial... | Clinical Trial